The overall goal of the Clinical Protocol and Data Management (CPDM) resource at Roswell Park is to assist investigators in the development, implementation, conduct, completion, and reporting of clinical trials in a scientifically rigorous and regulatory compliant manner. This goal is carried out by the Clinical Research Services, a centralized resource that oversees a broad portfolio of clinical trials, including institutional trials (investigator-initiated or IIT), national clinical trial network, other NCI-sponsored trials, and industry-sponsored trials. CRS provides infrastructure for all clinical research activities. CPDM staff assist investigators in assembling clinical and scientific content of protocols and developing budgets, as well as facilitating timely and effective protocol review and implementation. CPDM oversight of clinical research studies includes submission of the protocol, amendments, and continuing reviews to the Scientific Review Committee and the Institutional Review Board, and the management and tracking of all regulatory documents. CPDM staff provides administrative support to the Clinical Disease Teams for protocol prioritization and ongoing scientific relevance and the Data Safety Monitoring Committee. CPDM staff assist investigators in documentation of adverse events, outcomes, informed consent, accrual, and data items critical for safeguarding human subjects. CPDM ensures complete and accurate study data by entering the data in a centralized electronic research database. CPDM ensures that all adverse events and their attributions are reported promptly and accurately to the required internal and external regulatory agencies, and provides study sponsors and regulatory agencies with all required study documents. The CPDM has four specific aims: 1. Provide a central infrastructure including a clinical trial management system and technical staff to support Roswell Park investigators in their efforts to promote efficient and effective clinical trial development, activation, and outcome reporting. 2. Ensure clinical research performance in accordance with applicable regulations, policies, and procedures by providing training, and education. 3. Provide appropriate oversight and monitoring of all cancer-related Roswell Park clinical trials, ensuring participant safety, validity and integrity of the data collected, and quality control. 4. Coordinate and cultivate partnerships to promote and facilitate access and implementation of clinical trials within the Roswell Park catchment area, state of New York, and beyond.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016056-43
Application #
9923592
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-05-01
Budget End
2021-04-30
Support Year
43
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
824771034
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Eng, Diana G; Kaverina, Natalya V; Schneider, Remington R S et al. (2018) Detection of renin lineage cell transdifferentiation to podocytes in the kidney glomerulus with dual lineage tracing. Kidney Int 93:1240-1246
Ling, Xiang; Wu, Wenjie; Fan, Chuandong et al. (2018) An ABCG2 non-substrate anticancer agent FL118 targets drug-resistant cancer stem-like cells and overcomes treatment resistance of human pancreatic cancer. J Exp Clin Cancer Res 37:240
Chung, Sejin; Vail, Paris J; Witkiewicz, Agnieszka K et al. (2018) Coordinately targeting cell cycle checkpoint functions in integrated models of pancreatic cancer. Clin Cancer Res :
Mohammadpour, Hemn; O'Neil, Rachel; Qiu, Jingxin et al. (2018) Blockade of Host ?2-Adrenergic Receptor Enhances Graft-versus-Tumor Effect through Modulating APCs. J Immunol 200:2479-2488
Hsu, Alice H; Lum, Michelle A; Shim, Kang-Sup et al. (2018) Crosstalk between PKC? and PI3K/AKT Signaling Is Tumor Suppressive in the Endometrium. Cell Rep 24:655-669
Sandlesh, Poorva; Juang, Thierry; Safina, Alfiya et al. (2018) Uncovering the fine print of the CreERT2-LoxP system while generating a conditional knockout mouse model of Ssrp1 gene. PLoS One 13:e0199785
Zhang, Dingxiao; Zhao, Shuhong; Li, Xinyun et al. (2018) Prostate Luminal Progenitor Cells in Development and Cancer. Trends Cancer 4:769-783
Hong, Chi-Chen; Sucheston-Campbell, Lara E; Liu, Song et al. (2018) Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER Consortium. Cancer Epidemiol Biomarkers Prev 27:321-330
Damayanti, Nur P; Budka, Justin A; Khella, Heba W Z et al. (2018) Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma. Clin Cancer Res 24:5977-5989
Mayor, Paul; Starbuck, Kristen; Zsiros, Emese (2018) Adoptive cell transfer using autologous tumor infiltrating lymphocytes in gynecologic malignancies. Gynecol Oncol 150:361-369

Showing the most recent 10 out of 1555 publications